Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 348,190,432
  • Shares Outstanding, K 2,407,623
  • Annual Sales, $ 85,159 M
  • Annual Income, $ 35,153 M
  • EBIT $ 13,952 M
  • EBITDA $ 21,438 M
  • 60-Month Beta 0.51
  • Price/Sales 4.05
  • Price/Cash Flow 10.49
  • Price/Book 4.92

Options Overview Details

View History
  • Implied Volatility 19.85% ( -0.06%)
  • Historical Volatility 13.91%
  • IV Percentile 93%
  • IV Rank 73.57%
  • IV High 22.48% on 08/05/24
  • IV Low 12.53% on 05/09/24
  • Put/Call Vol Ratio 2.62
  • Today's Volume 36,349
  • Volume Avg (30-Day) 34,844
  • Put/Call OI Ratio 0.64
  • Today's Open Interest 384,688
  • Open Int (30-Day) 369,059

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 2.00
  • Number of Estimates 8
  • High Estimate 2.10
  • Low Estimate 1.94
  • Prior Year 2.29
  • Growth Rate Est. (year over year) -12.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
142.75 +0.89%
on 12/20/24
154.80 -6.96%
on 12/03/24
-10.78 (-6.96%)
since 12/02/24
3-Month
142.75 +0.89%
on 12/20/24
166.75 -13.63%
on 10/15/24
-17.15 (-10.64%)
since 10/02/24
52-Week
142.75 +0.89%
on 12/20/24
168.85 -14.71%
on 09/04/24
-15.95 (-9.97%)
since 01/02/24

Most Recent Stories

More News
5 Large Drug Stocks to Keep An Eye On in the New Year

The drug and biotech industry had a tough time in the past couple of months after Trump announced the appointment of Robert F. Kennedy Jr., a vaccine skeptic, as the head of Health and Human Services,...

AZN : 65.88 (+0.55%)
JNJ : 144.02 (-0.41%)
LLY : 778.07 (+0.79%)
ABBV : 179.44 (+0.98%)
PFE : 26.61 (+0.30%)
10 Stock Market Predictions for 2025

Here's what to expect from the stock market, along with some of Wall Street's hottest trends and most influential businesses, in the new year.

MSTR : 300.01 (+3.59%)
NVDA : 138.31 (+2.99%)
META : 599.24 (+2.34%)
AAPL : 243.85 (-2.62%)
$NASX : 19,280.79 (-0.16%)
$SPX : 5,868.55 (-0.22%)
JNJ : 144.02 (-0.41%)
PFE : 26.61 (+0.30%)
MSFT : 418.58 (-0.69%)
COMP : 5.80 (-0.85%)
BTC : 43.16 (+3.08%)
COST : 909.81 (-0.71%)
J&J Trading Near 52-Week Low: Should You Sell the Stock?

J&J’s JNJ stock closed at $145.05 on Friday, quite close to its 52-week low of $142.75. In the past three months, J&J’s stock has lost more than 10%.Slowing sales of J&J’s MedTech segment, the upcoming...

NVO : 87.52 (+1.74%)
JNJ : 144.02 (-0.41%)
LLY : 778.07 (+0.79%)
KVUE : 21.28 (-0.33%)
5 Unbeatable Stocks I'm Eager to Buy in 2025

These value, growth, and income stocks are incredibly cheap in a historically pricey stock market.

BABA : 84.95 (+0.19%)
COMP : 5.80 (-0.85%)
PUBM : 14.83 (+0.95%)
JNJ : 144.02 (-0.41%)
SIRI : 22.10 (-3.07%)
PFE : 26.61 (+0.30%)
Selling Covered Calls On The Dogs Of The Dow Stocks

The Dogs of the Dow is a long standing wall street strategy for investing in the stock market that involves purchasing the 10 highest yielding Dow Jones stocks.

VZ : 40.21 (+0.55%)
CVX : 146.71 (+1.29%)
KO : 61.84 (-0.67%)
JNJ : 144.02 (-0.41%)
MRK : 99.17 (-0.31%)
$IUXX : 20,975.62 (-0.17%)
MCD : 292.51 (+0.90%)
QQQ : 510.23 (-0.20%)
CSCO : 59.10 (-0.17%)
IBM : 219.94 (+0.05%)
PG : 165.98 (-1.00%)
$DOWI : 42,392.27 (-0.36%)
FDA proposes new testing rules to ensure cosmetics are asbestos-free

The Food and Drug Administration is proposing a rule that cosmetic companies would have to take extra steps to ensure that any products containing talc are free of asbestos

JNJ : 144.02 (-0.41%)
The Smartest Dividend Stocks to Buy With $1,000 Right Now

If you're looking for attractive dividend-paying stocks, that's a smart move. If you're not, perhaps reconsider -- because:

T : 22.83 (+0.26%)
JNJ : 144.02 (-0.41%)
KVUE : 21.28 (-0.33%)
ABBV : 179.44 (+0.98%)
FDA says decongestant in many cold medicines doesn't work. So what does?

The most popular nasal decongestant on U.S. pharmacy shelves may not be there much longer

JNJ : 144.02 (-0.41%)
Volatility Alert: 10 Stocks Showing High IV Percentile

Volatility can be an option trader's best friend or worst enemy, depending on how it's approached.

CVS : 44.22 (-1.49%)
MO : 52.51 (+0.42%)
WFC : 70.19 (-0.07%)
BAC : 44.29 (+0.77%)
KMI : 28.11 (+2.59%)
MRK : 99.17 (-0.31%)
JNJ : 144.02 (-0.41%)
UNH : 504.51 (-0.27%)
HMC : 28.43 (-0.42%)
ET : 19.71 (+0.61%)
Give Yourself the Gift That Will Keep On Giving in 2025 and Buy These 3 Top Dividend Stocks

Dividend-paying stocks are the gift that keeps on giving. They pay you a recurring stream of passive income that you can use to make new investments or cover some of your expenses. The best dividend stocks...

KO : 61.84 (-0.67%)
JNJ : 144.02 (-0.41%)
NEE : 71.61 (-0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among...

See More

Key Turning Points

3rd Resistance Point 147.26
2nd Resistance Point 146.51
1st Resistance Point 145.27
Last Price 144.02
1st Support Level 143.28
2nd Support Level 142.53
3rd Support Level 141.29

See More

52-Week High 168.85
Fibonacci 61.8% 158.88
Fibonacci 50% 155.80
Fibonacci 38.2% 152.72
Last Price 144.02
52-Week Low 142.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar